SCHEMBL17320649

SCHEMBL17320649

Cc1cc(C=O)cc([N+](=O)[O-])c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.53
CYP1A2 P05177 1/20 0.52
ALDH5A1 P51649 1/20 0.49
ABAT P80404 1/20 0.49
VCAM1 P19320 1/20 0.49
TSHR P16473 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALDH3A1 P30838 2/20 0.45
ALDH1A1 P00352 4/20 0.43
MAPT P10636 2/20 0.41
ALDH1A3 P47895 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP3A4 P08684 3/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALOX15 P16050 1/20 0.40
PRKDC P78527 1/20 0.40
CCR6 P51684 1/20 0.40
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14035450 0.90 XDH (0.58) XDHCYP1A2ALDH5A1ABATVCAM1
SCHEMBL3601360 0.83 XDH (0.51) XDHCYP1A2ALDH5A1ABATVCAM1
SCHEMBL531803 0.81 XDH (0.69) XDHALDH5A1ABATVCAM1ALDH1A1
SCHEMBL12777072 0.79 ALDH1A1 (0.54) XDHCYP1A2ALDH5A1ABATVCAM1
SCHEMBL1814040 0.78 ALDH1A1 (0.50) XDHALDH5A1ABATVCAM1TSHR
SCHEMBL19785604 0.78 TSHR (0.53) XDHALDH5A1ABATVCAM1TSHR
SCHEMBL1826371 0.77 ALDH5A1 (0.58) XDHCYP1A2ALDH5A1ABATVCAM1
SCHEMBL29952850 0.77 ALDH5A1 (0.58) XDHCYP1A2ALDH5A1ABATVCAM1
SCHEMBL335971 0.77 ALDH5A1 (0.62) XDHCYP1A2ALDH5A1ABATVCAM1
SCHEMBL814444 0.76 SRC (0.48) CYP1A2TSHRALDH1A1ALDH1A3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111763191-A Preparation method of DMXAA 河北中科金辉药业有限公司 2020-10-13 CN disclosed
US-9580379-B2 Xanthine oxidase inhibitors and methods of use BAYLOR COLLEGE OF MEDICINE (US) 2017-02-28 US disclosed
US-20150353471-A1 XANTHINE OXIDASE INHIBITORS AND METHODS OF USE BAYLOR COLLEGE OF MEDICINE 2015-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353471-A1 XANTHINE OXIDASE INHIBITORS AND METHODS OF USE XDH, PNPO, AOX1 XDH 1/4885CYP1A2 104/4885ALDH5A1 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.